ClassID:

93525

C07C317/42 - CPC Classification

Classification description:

Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups , X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones Y being a hetero atom

Recent Application in this class:
#1
20250250229
2025-08-07

ARYLTHIO DERIVATIVES WITH PHARMACOLOGICAL ACTIVITY

#2
20240409504
2024-12-12

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

#3
20240300968
2024-09-12

6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES

#4
20240285584
2024-08-29

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS

#5
20220363629
2022-11-17

Polymorphic forms of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzolsulfonamide

#6
20220202777
2022-06-30

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS

#7
20220106265
2022-04-07

Compositions and methods for the treatment of cancer

#8
20220041923
2022-02-10

Heat-sensitive recording material

#9
20210355074
2021-11-18

Cycloheptylamine derivatives as anti-diabetic agents

#10
20210347725
2021-11-11

Cycloheptylamine derivatives as anti-diabetic agents

#11
20200283403
2020-09-10

Compounds and compositions for the inhibition of NAMPT

#12
20200190031
2020-06-18

ARYL ETHERS AND USES THEREOF

#13
20200109110
2020-04-09

Sulfur derivatives as chemokine receptor modulators

#14
20190343804
2019-11-14

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#15
20190270721
2019-09-05

Compounds and compositions for the inhibition of NAMPT

#16
20190119214
2019-04-25

Aryl ethers and uses thereof

#17
20190010135
2019-01-10

1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

#18
20180291000
2018-10-11

Compounds and compositions for the inhibition of NAMPT

#19
20180244612
2018-08-30

Method of producing a sodium salt of (2,6-dichlorophenyl)amide carbopentoxysulfanilic acid

#20
20180228772
2018-08-16

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#21
20180155279
2018-06-07

Aryl ethers and uses thereof

#22
20170275301
2017-09-28

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#23
20170166519
2017-06-15

Use of DDX3X inhibitors for the treatment of pneumovirus infections

#24
20170119737
2017-05-04

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#25
20160251307
2016-09-01

Aryl ethers and uses thereof

#26
20160235711
2016-08-18

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#27
20160083342
2016-03-24

Sulfur derivatives as chemokine receptor modulators

#28
20160000084
2016-01-07

Use of acylsulfonamides for improving plant yield

#29
20150148395
2015-05-28

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#30
20140094614
2014-04-03

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#31
20130109866
2013-05-02

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#32
20120157487
2012-06-21

Sulfur derivatives as chemokine receptor modulators

#33
20120157413
2012-06-21

Phosphorous derivatives as chemokine receptor modulators

#34
20100197640
2010-08-05

Sulfamoyl-phenyl-ureido compounds and their use as medicament

#35
20090176786
2009-07-09

Benzoylurea Compounds and Use Thereof

#36
20090170824
2009-07-02

Diarylsulfones as 5-HT2A Antagonists

#37
20090143592
2009-06-04

Glucagon Antagonists/Inverse Agonists

#38
20080207622
2008-08-28

SOLUBLE EPOXIDE HYDROLASE INHIBITORS

#39
20070281952
2007-12-06

Arylsulfonylnaphthalene derivatives as 5HTantagonists

#40
20070265345
2007-11-15

Novel Biphenyl Compounds And Their Use

#41
20070238763
2007-10-11

Urea derivatives as integrin a4 antagonists

#42
20070203205
2007-08-30

Diarylsulfones as 5-HT2A antagonists

#43
20060135503
2006-06-22

Cyclic derivatives as modulators of chemokine receptors activity

#44
20060052445
2006-03-09

Diarylsulfones as 5-HT2A antagonists

#45
20050203108
2005-09-15

Glucagon antagonists/inverse agonists

#46
20050059611
2005-03-17

Glucagon antagonists/inverse agonists

#47
20050038028
2005-02-17

Hydroxyethylene compounds with Asp2 inhibitory activity